Helmerich & Payne Inc. Common Stock vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Helmerich & Payne Inc. Common Stock trades at $38.46 (market cap $3.91B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Helmerich & Payne Inc. Common Stock and Indivior Pharmaceuticals Inc. Common Stock are close in size by market cap, and Helmerich & Payne Inc. Common Stock pays a 2.56% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Helmerich & Payne Inc. Common Stock for 0 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| HP | INDV | |
|---|---|---|
Market Cap | $3.91B | $4.18B |
Volume | 800,382 | 1,819,746 |
Sector | Energy | Health |
52-Week High | $47.64 | $41.83 |
52-Week Low | $23.11 | $24.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.54B | $4.47B |
Dividend Yield | 2.56% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Helmerich & Payne, Inc. is a US drilling contractor that designs, builds, and operates high-performance land and offshore drilling rigs for oil and gas producers worldwide.
Read more on HP →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →